Hepatitis C treatment is no longer prohibitively expensive in the Global South because Malaysia, Thailand, Egypt and the Drugs for Neglected Diseases initiative developed ravidasvir – a low-cost antiviral. Such breakthroughs are possible for other neglected diseases if low- and middle-income countries agree to act collectively.
Chinese policymakers face difficult choices in setting climate goals. Some appear technical but have significant implications for environmental outcomes.
Across the region, it’s never been more critical to cultivate a resilient healthcare workforce capable of addressing climate-induced public health issues.